It is worth noting that reMAIT cells would have to be considered for specific cancers in which MAIT cell ligands are available, such as colorectal cancer or in combination with microbe-based therapy as discussed earlier, because the cytolytic activity of MAIT cells would be dependent on microbial ligands presented on MR1. The gene discussed is MR1; the disease is cancer.